Comparative cardiac effects of antimalarial drug halofantrine with or without concomitant administration of kolanut or fluconazole in healthy volunteers.

Adedapo, Aduragbenro DA; Ojji, Dike B; Adedapo, Kayode S; Kolade, Yetunde; Babalola, Chinedum P

Adedapo, Aduragbenro DA; Ojji, Dike B; Adedapo, Kayode S; Kolade, Yetunde; Babalola, Chinedum P.

Afiliación

Adedapo AD; Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria.
Ojji DB; Department of Clinical Pharmacology, University College Hospital, Ibadan, Oyo State, Nigeria.
Adedapo KS; Cardiology Unit, Medicine Department, Gwagwalada Hospital, Abuja, Nigeria.
Kolade Y; Department of Chemical Pathology, University of Ibadan, Ibadan, Nigeria.
Babalola CP; Department of Pharmaceutical Chemistry, University of Ibadan, Ibadan, Nigeria.

Afr Health Sci ; 23(1): 262-269, 2023 Mar.

Article en En | MEDLINE | ID: mdl-37545974

Asunto(s)

Antimaláricos; Humanos; Antimaláricos/efectos adversos; Estudios Cruzados; Electrocardiografía; Fluconazol/efectos adversos; Voluntarios Sanos

Palabras clave

Drug interaction; QT prolongation; fluconazole; halofantrine; kolanut; malaria

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antimaláricos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Afr Health Sci Asunto de la revista: MEDICINA / SERVICOS DE SAUDE Año: 2023 Tipo del documento: Article País de afiliación: Nigeria Pais de publicación: Uganda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google